Accurate coding is essential for epidemiological surveillance, clinical audit, reimbursement processes, and pharmacovigilance activities
Guideline I.C.4 Endocrine, Nutritional, and Metabolic Diseases (E00E89) Obesity codes require physician documentation
Accurate ICD-10 coding in electronic health records facilitates systematic identification of adverse drug reactions for both local clinical governance and national pharmacovigilance purposes
acts on reward circuitry Setmelanotide (Imcivree): MC4R agonist for genetic obesity (LEPR, POMC deficiencies) SGLT2 inhibitors (empagliflozin, dapagliflozin): Not FDA-approved for obesity alone but cause weight loss
A BMI value in the chart is NOT sufficient to assign an obesity code physician documentation of the obesity diagnosis is required per FY2026 ICD-10-CM Official Guidelines, Section I.C.21.c.3